FDA Approves First Medication for Obstructive Sleep Apnea
Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity, to be used in...
Zepbound Approved to Treat Obstructive Sleep Apnea
Jan 3, 2025 · Zepbound is the first medication for obstructive sleep apnea to receive FDA approval . This breakthrough for sleep apnea treatment received FDA approval in December …
Zepbound® (tirzepatide) Injection for Adults with Obstructive Sleep Apnea
Zepbound is an injectable prescription medicine that may help adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity to improve their OSA. Zepbound should be used …
FDA Approves Zepbound for Obstructive Sleep Apnea - WebMD
Dec 23, 2024 · Results showed that Zepbound significantly reduced breathing interruptions (apnea and hypopnea) during sleep compared to the placebo. More patients treated with …
What is Zepbound | Obstructive Sleep Apnea | Zepbound® …
Zepbound is an injectable prescription medicine that may help adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity to improve their OSA. Zepbound should be used …
Zepbound approval for sleep apnea | AASM statement
Dec 23, 2024 · The FDA approval of Zepbound for moderate to severe obstructive sleep apnea in adults with obesity is a positive development for patients and clinicians, who now have another …
Tirzepatide reduced sleep apnea severity by up to nearly two …
Apr 17, 2024 · SURMOUNT-OSA (NCT05412004) was a multi-center, randomized, double-blind, parallel, placebo-master protocol comparing the efficacy and safety of tirzepatide to placebo in …
FDA approves Zepbound® (tirzepatide) as the first and only …
Dec 20, 2024 · Zepbound ® (tirzepatide) injection is FDA-approved to treat adults with moderate-to-severe obstructive sleep apnea and obesity. It is also approved in combination with a …
Zepbound approved by FDA as first sleep apnea medication
Jan 9, 2025 · On Dec. 20, Eli Lilly announced the FDA has approved Zepbound (tirzepatide) as the first and only prescription medication for adults with moderate-to-severe obstructive sleep …
FDA Approves Zepbound as First Drug for Obstructive Sleep Apnea
Jan 2, 2025 · The US Food and Drug Administration (FDA) approved Eli Lilly and Co.'s tirzepatide (Zepbound) for moderate to severe obstructive sleep apnea (OSA) in adults with obesity on …
- Some results have been removed